1. Home
  2. IDCC vs IOVA Comparison

IDCC vs IOVA Comparison

Compare IDCC & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InterDigital Inc.

IDCC

InterDigital Inc.

N/A

Current Price

$317.18

Market Cap

6.6B

Sector

Miscellaneous

ML Signal

N/A

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

N/A

Current Price

$8.73

Market Cap

6.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IDCC
IOVA
Founded
1972
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.6B
6.7B
IPO Year
2007
2008

Fundamental Metrics

Financial Performance
Metric
IDCC
IOVA
Price
$317.18
$8.73
Analyst Decision
Strong Buy
Buy
Analyst Count
4
9
Target Price
★ $462.67
$14.30
AVG Volume (30 Days)
161.0K
★ 13.5M
Earning Date
10-29-2026
11-05-2026
Dividend Yield
★ 0.95%
N/A
EPS Growth
N/A
★ 14.84
EPS
★ 7.86
N/A
Revenue
★ $307,404,000.00
N/A
Revenue This Year
N/A
$57.19
Revenue Next Year
N/A
$43.78
P/E Ratio
$40.36
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$249.14
$1.76
52 Week High
$387.30
$15.37

Technical Indicators

Market Signals
Indicator
IDCC
IOVA
Relative Strength Index (RSI) 42.72 31.66
Support Level $293.62 $7.85
Resistance Level $348.21 $9.36
Average True Range (ATR) 12.48 1.00
MACD -1.49 -0.93
Stochastic Oscillator 9.30 9.87

Price Performance

Historical Comparison
IDCC
IOVA

About IDCC InterDigital Inc.

InterDigital Inc is a research and development company focused on wireless, Video, Artificial Intelligence, and related Technologies. It designs and develops technologies that enable connected, immersive experiences in a broad range of communications and entertainment products and services. The majority of revenue is generated from fixed-fee patent license agreements, with a smaller portion coming from variable royalty agreements. Geographically, it operates in the United States, China, South Korea, Japan, Taiwan, and Europe, with the majority is from China.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: